Clinical Response to Futibatinib in Patients with High-Level FGFR2-Amplified Advanced Gastric Cancer: Two Case Reports.
- Published in:
- 2022
- By:
- Publication type:
- Case Study
Works matching IS 11732563 AND DT 2022 AND VI 42 AND IP 8
Results: 8
1
2
Paxlovid-Tacrolimus Drug–Drug Interaction in a 23-Year-Old Female Kidney Transplant Patient with COVID-19.
- Published in:
- Clinical Drug Investigation, 2022, v. 42, n. 8, p. 693, doi. 10.1007/s40261-022-01180-4
- By:
- Publication type:
- Article
3
Pharmacokinetic Drug–Drug Interaction Studies Between Trilaciclib and Midazolam, Metformin, Rifampin, Itraconazole, and Topotecan in Healthy Volunteers and Patients with Extensive-Stage Small-Cell Lung Cancer.
- Published in:
- Clinical Drug Investigation, 2022, v. 42, n. 8, p. 679, doi. 10.1007/s40261-022-01179-x
- By:
- Publication type:
- Article
4
Nonmetastatic Castration-Resistant Prostate Cancer: Current Challenges and Trends.
- Published in:
- Clinical Drug Investigation, 2022, v. 42, n. 8, p. 631, doi. 10.1007/s40261-022-01178-y
- By:
- Publication type:
- Article
5
Modeling the Potential Impact of Remdesivir Treatment for Hospitalized Patients with COVID-19 in Saudi Arabia on Healthcare Resource Use and Direct Hospital Costs: A Hypothetical Study.
- Published in:
- Clinical Drug Investigation, 2022, v. 42, n. 8, p. 669, doi. 10.1007/s40261-022-01177-z
- By:
- Publication type:
- Article
6
Correction to: Foreword.
- Published in:
- 2022
- By:
- Publication type:
- Correction Notice
7
Cost-Effectiveness of Icosapent Ethyl, Evolocumab, Alirocumab, Ezetimibe, or Fenofibrate in Combination with Statins Compared to Statin Monotherapy.
- Published in:
- Clinical Drug Investigation, 2022, v. 42, n. 8, p. 643, doi. 10.1007/s40261-022-01173-3
- By:
- Publication type:
- Article
8
Bioavailability Evaluation of Venetoclax Lower-Strength Tablets and Oral Powder Formulations to Establish Interchangeability with the 100 mg Tablet.
- Published in:
- Clinical Drug Investigation, 2022, v. 42, n. 8, p. 657, doi. 10.1007/s40261-022-01172-4
- By:
- Publication type:
- Article